Shuai Y - Search Results

1

Clinicopathologic characteristics and prognostic significance of HER2-low expression in patients with early breast cancer: A systematic review and meta-analysis.

Wei T, Wang D, Gao S, Wang X, Yue J, Kang Y, Ju J, Yang Z, Shuai Y, Yuan P. Wei T, et al. Among authors: shuai y. Front Oncol. 2023 Feb 2;13:1100332. doi: 10.3389/fonc.2023.1100332. eCollection 2023. Front Oncol. 2023. PMID: 36816954 Free PMC article.

2

Liquid-based biomarkers in breast cancer: looking beyond the blood.

Shuai Y, Ma Z, Ju J, Wei T, Gao S, Kang Y, Yang Z, Wang X, Yue J, Yuan P. Shuai Y, et al. J Transl Med. 2023 Nov 13;21(1):809. doi: 10.1186/s12967-023-04660-z. J Transl Med. 2023. PMID: 37957623 Free PMC article. Review.

3

Prognostic factors and benefit populations of ovarian function suppression in premenopausal HR+/HER2+ early-stage breast cancer patients who received trastuzumab: Evidence from a real-world study with long-term follow-up.

Ju J, Gao SL, Wang JY, Sang D, Kang YK, Wang X, Yue J, Shuai Y, Qi YX, Yuan P. Ju J, et al. Among authors: shuai y. Thorac Cancer. 2024 Feb;15(6):439-447. doi: 10.1111/1759-7714.15211. Epub 2024 Jan 7. Thorac Cancer. 2024. PMID: 38185807 Free PMC article.

4

Disulfidptosis: disulfide stress-induced novel cell death pathway.

Shuai Y, Ma Z, Yuan P. Shuai Y, et al. MedComm (2020). 2024 Jun 29;5(7):e579. doi: 10.1002/mco2.579. eCollection 2024 Jul. MedComm (2020). 2024. PMID: 38948113 Free PMC article.

5

Exploring risk factors for endocrine-related immune-related adverse events: Insights from meta-analysis and Mendelian randomization.

Quan L, Liu J, Wang Y, Yang F, Yang Z, Ju J, Shuai Y, Wei T, Yue J, Wang X, Meng J, Yuan P. Quan L, et al. Among authors: shuai y. Hum Vaccin Immunother. 2024 Dec 31;20(1):2410557. doi: 10.1080/21645515.2024.2410557. Epub 2024 Oct 8. Hum Vaccin Immunother. 2024. PMID: 39377304 Free PMC article.

6

Spatial assessment of drinking water flavor in China: Revealing regional disparities and underlying drivers.

Shuai Y, Zhang K, Zhang T, Zhu H, Jin S, Hu T, Yu Z, Liang X. Shuai Y, et al. Water Res. 2024 Dec 20;273:123020. doi: 10.1016/j.watres.2024.123020. Online ahead of print. Water Res. 2024. PMID: 39752979

7

DPFunc: accurately predicting protein function via deep learning with domain-guided structure information.

Wang W, Shuai Y, Zeng M, Fan W, Li M. Wang W, et al. Among authors: shuai y. Nat Commun. 2025 Jan 2;16(1):70. doi: 10.1038/s41467-024-54816-8. Nat Commun. 2025. PMID: 39746897 Free PMC article.

8

LOC730101 improves ovarian cancer drug sensitivity by inhibiting autophagy-mediated DNA damage repair via BECN1.

Zhong Y, Shuai Y, Yang J, Zhang M, He T, Zheng L, Yang S, Peng S. Zhong Y, et al. Among authors: shuai y. Cell Death Dis. 2024 Dec 18;15(12):893. doi: 10.1038/s41419-024-07278-1. Cell Death Dis. 2024. PMID: 39695078 Free PMC article.

9

Colored thermal camouflage and anti-counterfeiting with programmable In₃SbTe₂ platform.

Zhou S, Dong S, Guo Y, Shuai Y, Xu HX, Hu G. Zhou S, et al. Among authors: shuai y. Nanophotonics. 2024 Feb 28;13(6):945-954. doi: 10.1515/nanoph-2023-0924. eCollection 2024 Mar. Nanophotonics. 2024. PMID: 39634368 Free PMC article.

10

The N6-methyladenosine writer METTL3 promotes breast cancer progression through YTHDF2-dependent posttranscriptional silencing of GSDMD.

Shuai Y, Ma Z, Ju J, Li C, Bai X, Yue J, Wang X, Yuan P, Qian H. Shuai Y, et al. Apoptosis. 2024 Dec 3. doi: 10.1007/s10495-024-02037-1. Online ahead of print. Apoptosis. 2024. PMID: 39627574

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

405 results

Search Page

Filters